WO2000056263A1 - Suppository package and production method therefor - Google Patents

Suppository package and production method therefor Download PDF

Info

Publication number
WO2000056263A1
WO2000056263A1 PCT/JP2000/001761 JP0001761W WO0056263A1 WO 2000056263 A1 WO2000056263 A1 WO 2000056263A1 JP 0001761 W JP0001761 W JP 0001761W WO 0056263 A1 WO0056263 A1 WO 0056263A1
Authority
WO
WIPO (PCT)
Prior art keywords
suppository
container
filler
package
space
Prior art date
Application number
PCT/JP2000/001761
Other languages
French (fr)
Japanese (ja)
Inventor
Ikuo Koyama
Original Assignee
Taisho Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co., Ltd. filed Critical Taisho Pharmaceutical Co., Ltd.
Priority to AU33256/00A priority Critical patent/AU3325600A/en
Publication of WO2000056263A1 publication Critical patent/WO2000056263A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/08Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of suppositories or sticks

Definitions

  • the present invention relates to a suppository package and a method for producing the suppository package in which the suppository body is contained or stored in a container, and particularly to a suppository package suitable for storage and distribution at a high temperature. It relates to the manufacturing method. Background art
  • suppositories remain in a solid state at room temperature, but melt in the rectum due to body temperature to release the drug. Therefore, suppositories are widely used for administration of drugs that are preferably absorbed through the rectal mucosa.
  • suppositories are manufactured by adding a drug or the like to an oily base, and are usually stored or passed through a suppository package packed in a plastic suppository container. I have. Since the melting point of suppositories is usually set at about 30 to 37 ° C, suppository packages should usually be cooled and solidified after the suppository is poured into the suppository container in a molten state. It is manufactured by.
  • Japanese Patent Publication No. 58-82869 proposes that a small piece of solid foamed plastic is inserted into a space in a suppository container and sealed.
  • deformation of the suppository body could not be completely prevented.
  • the production of small pieces of foamed plastic that fits into a relatively small space in a suppository container requires many additional steps, and the insertion of the small pieces into the container requires Since special jigs were required, there were also problems in terms of manufacturing equipment, time and cost.
  • the small pieces of foamed plastic are simply enclosed in the container together with the suppository, so that when the container is opened, the small pieces fall off the container. This not only caused anxiety to the user, but also required extra work to dispose of the small pieces. Disclosure of the invention
  • An object of the present invention is to solve the above-mentioned problems in the storage or distribution stage of suppositories. That is, an object of the present invention is to provide a novel suppository package in which a suppository is not deformed even when stored or distributed in a temperature environment equal to or higher than body temperature, and a method for producing the same. .
  • the suppository package of the present invention is a suppository package comprising a suppository and a container containing the suppository, wherein the entire space between the suppository and the container is sealed with a filler. It is characterized by having.
  • the space may exist adjacent only to the end of the suppository.
  • the “end” refers to the end in the direction along the long axis of the suppository, and it is sufficient that there is a space to be filled adjacent to at least one end of the suppository body.
  • the filler used in the present invention preferably has a flow start temperature of 50 ° C. or higher.
  • the “flow start temperature” is a temperature at which the filler starts melting and softening to start fluidization.
  • the specific value of the flow start temperature depends on the material of the filler and the measuring method.
  • the flow onset temperature is synonymous with the melting point (including the crystal melting point), and can be measured according to JISK7121.
  • the flow start temperature has the same meaning as the softening temperature, and can be measured, for example, according to JISK720.
  • the filler is fixed to the container.
  • the filler is more preferably integrated with the seal portion.
  • the filler does not contain an eluted component, and it is particularly preferable that the filler is a hot melt adhesive.
  • the “eluting component” mentioned above refers to any substance that elutes from the filler to the outside of the filler under any action or condition.
  • the method for producing a suppository package of the present invention includes: an introduction step of introducing a suppository from the container entrance into the interior of the container; and a filling step of filling a space between the suppository and the container with a fluid filler. And a sealing step of sealing the container entrance.
  • the introduction step may include a step of injecting a fluid suppository into the container and a step of solidifying the suppository.
  • the filling in the filling step is preferably performed via the container inlet, and the container inlet is preferably sealed together with the filler.
  • the flow start temperature of the filler is preferably 50 ° C. or higher. Further, it is preferable that the filler does not contain an eluted component, and in particular, it is preferable that the filler is a hot-melt adhesive.
  • the present invention also includes a suppository package produced by the above-mentioned production methods.
  • a suppository package comprising a suppository and a container containing the suppository, wherein the suppository is deformed by filling a space in the container with a fluid filler.
  • the flow start temperature of the filler is preferably 50 ° C. or higher.
  • FIG. 1 is a longitudinal sectional view showing a conventional suppository package and a manufacturing process thereof.
  • FIG. 2 is a longitudinal sectional view showing one embodiment of a suppository package and a method for producing the same according to the present invention.
  • FIG. 3 is a longitudinal sectional view showing the opened state of the suppository package of the present invention. Detailed description of the invention
  • the present inventors have studied in detail the mechanism by which a suppository deforms when exposed to a high temperature of body temperature or higher during the storage or distribution process, and found that the suppository is deformed by a suppository and a suppository including the suppository. It was found that this was caused by the existence of a gap between the agent container. In other words, if the suppository melts in a container with a void inside and the container rolls over or reverses, the suppository moves into the void and the original suppository deforms. However, if the temperature drops in this state, the suppository will harden in the deformed state.
  • FIG. 1 is a longitudinal sectional view showing a conventional type of suppository package and its manufacturing process
  • FIG. 1 (a) shows a suppository container 2 before sealing, filled with a predetermined amount of a suppository 1.
  • FIG. 1 (b) shows a state where the entrance 2a of the suppository container 2 is sealed along the line X-X in FIG. 1 (a).
  • a conventional type of suppository package is to introduce a high-temperature molten suppository 1 into a suppository container 2 and then cool it at room temperature to solidify the suppository 1, followed by It is manufactured by sealing the entrance 2a of the suppository container 2.
  • the suppository 1 in the suppository container 2 shrinks when it solidifies, so that the suppository 1 generally has a shape in which the center of the surface is depressed.
  • the suppository since the suppository is deformed due to the existence of free space in the container, it is preferable to avoid the space in the container in order to prevent the suppository from being deformed. Therefore, for example, in the example of FIG. In order to avoid this, it is conceivable that all the spaces in the suppository container 2 are densely filled with the suppository 1 in the manufacture of the suppository package.
  • the gap 3 in the container 2 is such that the suppository 1 is prevented from being pinched and the seal of the inlet 2 a of the container 2 is completed. It is essential, and it is preferable that the volume is as large as possible. Therefore, in order to prevent deformation of the suppository 1 in the container 2, the void 3 in the container 2 should be eliminated in order to prevent the deformation of the suppository 1 in the container 2. It is not feasible to densely fill the container 2 in view of the sealing property of the container 2.
  • the present inventor has conducted intensive studies on a novel suppository package and a method for producing the suppository package which can completely seal the container without generating a void in the suppository container. It has been found that a method of sealing the entrance of the container with the fluid filler filled in the space between the suppository and the inner surface of the suppository container has been found to be useful.
  • FIG. 2 is a longitudinal sectional view showing an embodiment of a suppository package 5 and a method for producing the suppository package according to the present invention
  • FIG. 2 (a) shows a state before an entrance 2a of a suppository container 2 is sealed. Indicates the status.
  • FIG. 2 (b) the entrance 2a of the suppository container 2 is sealed together with the filler 4 as described later along the line X--X in FIG. 2 (a) to form a seal portion 2a '.
  • the present invention o
  • FIG. 5 shows a suppository package 5 of the present invention.
  • the suppository container 2 is formed by bonding two sheets having the same shape of a concave portion with the concave portion facing each other, and a space formed by the concave portion. Suppository 1 is held in it. However, a part of the sheets is not bonded to each other, and forms an entrance 2a to the space.
  • the shape of the space formed by the container 2 is not particularly limited, but in order to facilitate the use of the suppository 1, the space must be substantially spindle-shaped with a long axis Z as shown in the figure. Is preferred.
  • the material of the suppository container 2 is not particularly limited, and for example, a general-purpose synthetic resin material such as polyethylene, polypropylene, polyvinyl chloride, polystyrene, or polyester can be used. In this respect, polyolefin-based synthetic resin materials such as polyethylene and polypropylene are preferable. Further, the sheets constituting the suppository container 2 may be a laminate of sheets made of a plurality of different materials.
  • the type of the base of the suppository 1 held in the suppository container 2 and the type of the drug to be mixed therewith are not particularly limited.
  • the base include caprylic acid, capric acid, pelagonic acid, pendecylic acid, tridecylic acid, lauric acid, myristic acid, noremitic acid, penicillic acid, heptamine decylic acid, stearic acid, and oleic acid.
  • unsaturated fatty acids such as elaidic acid, linoleic acid and linoleic acid, and unsaturated fatty acid glycerin esters. These can be used alone or in admixture of two or more, if necessary. Usually, a mixture of mono-, di- and triesters of unsaturated or saturated fatty acid and glycerin is preferable.
  • a nonionic surfactant such as alkyl phenyl ether and polyoxyethylene castor oil.
  • the oleaginous components include sesame oil, olive oil, camellia oil, soybean oil, rapeseed oil, cottonseed oil, linseed oil, castor oil, nuka oil, corn oil, peanut oil, coconut oil, fragrant oil, avogard oil, Palm oil, palm kernel oil, cocoa oil, royal hook oil, kuromoji oil, sazanka oil, charcoal oil, eno oil, cocoa butter, 20 cay fat, laurin fat, beef fat, lard, wool fat, turtle oil , Squalene, etc., and modified fats and oils obtained by chemically changing these animal and vegetable fats and oils by hydrogenation, fatty acid conversion, acetylation, fractional extraction, etc., cerin, white cerin, liquid paraffin, paraffin, Mineral oils such as dehydrated lanolin, silicone oils, etc.
  • the drug to be incorporated in suppository 1 is appropriately selected depending on the target of treatment and the like.
  • Antipyretic analgesics and anti-inflammatory drugs such as diflucortron valerate, hydrocortidone acetate, betamethasone, etc., corticosteroids such as morphine hydrochloride, alkaloid drugs such as morphine hydrochloride, drugs for digestive organs such as domperisone, tegafur, fluorouracil Antimetabolites such as gemprost; sedatives such as diazepam and phenobarbital; sedatives such as anxiolytics and visacodyl; enemas; sulphas such as salazosulfaviridine; ceftidixim sodium; Broncho
  • Suppository 1 may further contain a drug such as a local anesthetic, an anti-histamine, a bactericide, a vitamin, an amino acid, or a bile acid, if necessary. Further, other auxiliary ingredients can be added to the suppository 1 as needed. o
  • auxiliary component examples include water, a stabilizer, a preservative, a coloring agent, a fragrance, a dispersant, a thickener, a pH regulator, a wetting agent, an antioxidant, a preservative, and an excipient.
  • the suppository package 5 in the present embodiment is manufactured as follows.
  • the suppository 1 in a molten state is introduced into the space in the suppository container 2 via a nozzle (not shown).
  • the suppository 1 is not completely filled in the space in the suppository container 2 but is filled to a certain height from the bottom.
  • the suppository 1 is cooled and solidified at room temperature.
  • a solid suppository 1 having a surface shape matching the shape of the container 2 is prepared in advance in a separate process, inserted into the container 2, and the suppository 1 is introduced into the container 2. Is also good.
  • the space remaining in the suppository container 2 is densely filled with the fluid filler 4 via a supply means (not shown).
  • the filling path of the filler 4 into the space is not particularly limited, but it is preferable that the filler 4 is filled from the inlet 2a in terms of working efficiency.
  • the space in the container 2 to be filled with the filler 4 is the length of the suppository 1. It is preferably present only adjacent to the end along the axis Z. In addition, in terms of ease of filling with the filling material 4, the space to be filled with the filling material 4 is adjacent to the end of the suppository 1 near the entrance 2a of the container 2, as shown in FIG. It is preferable that they exist.
  • the surface of the suppository 1 sinks into various shapes for each container, so the inside of the container 2 as described in JP-A-58-82869 is disclosed.
  • the fluid filler Since the suppository 1 is used, the space in the container 2 is completely filled with the filler 4 irrespective of the shape of the concave depression on the end surface generated when the suppository 1 solidifies. Therefore, no void remains in the suppository container 2.
  • the material of the filler 4 is not particularly limited, but it must be a substance that maintains a solid shape even in a high-temperature environment that may occur in the storage and / or distribution process of the suppository package. Is preferred. Therefore, specifically, the flow start temperature of the filler 4 is preferably 50 ° C. or higher, more preferably 70 ° C. or higher, and most preferably 90 ° C. or higher. If the temperature is lower than 50 ° C, the filler 4 may be melted and integrated with the suppository 1 during the storage and / or distribution of the suppository package.
  • the filler 4 may cause thermal deterioration of the suppository 1 when introduced into the suppository container 2, so that the flow start temperature of the filler 4
  • the temperature is preferably 150 ° C. or lower, more preferably 130 ° C. or lower, and most preferably 110 ° C. or lower.
  • the physical properties of the filler 4 in a fluid state are not particularly limited as long as the space in the suppository container 2 is completely filled and the suppository 1 is prevented from moving. Or it may be in a paste form or the like. However, in view of the ease of introduction into the suppository container 2 and the ease of sealing the suppository container 2, it is preferable that the viscosity of the filler 4 can be controlled by means such as heating.
  • Examples of the material of the filler 4 that satisfies the above preferable characteristics include synthetic and / or natural polymer materials.
  • a hot-melt adhesive in view of adhesiveness to the container 2 and sealing of the inlet 2a.
  • a so-called reactive hot-melt adhesive may be used, in addition to one that melts by heating to exhibit adhesiveness and solidifies by cooling to maintain an adhesive state. it can.
  • hot melt type adhesives examples include, for example, polyethylene resin, polypropylene, and polyolefin resin-based adhesives, polybutylene polyamide, polyamide-based adhesives such as nylon-11, nylon-11, and the like. , Acryl resin adhesives, polyvinyl acetate adhesives, polyester adhesives, polyvinyl acetal adhesives such as polyvinyl butyral, ethylene-vinyl acetate copolymer adhesives, thermoplastic elastomer adhesives And urethane-based hot-melt adhesives, etc., but preferably do not contain elution components harmful to the human body.
  • Filler 4 comes in contact with suppository 1, so the material of filler 4 should be water, organic solvent, polymerization initiator, cross-linking agent in order to prevent undesired components from migrating to suppository 1. It is preferred that various components such as unpolymerized monomers are not eluted, or at least very little. It is preferable that the filler 4 is fixed to the suppository container 2 from the viewpoints of the shape retention of the suppository 1 and the easiness of handling at the time of opening. Examples of a method of fixing the filler 4 to the suppository container 2 include a mode in which at least a part of the filler 4 is adhered to the suppository container 2 using an adhesive, but the manufacturing process is simplified.
  • the filler 4 itself be made of a material having adhesiveness or adhesiveness to the suppository container 2. However, in this case, it is preferable that the material constituting the filler 4 does not adhere to or adhere to the suppository 1.
  • the entrance 2a of the suppository container 2 is sealed.
  • Various methods such as sealing with an adhesive, heat sealing by contact or pressing with a heating means, and closing with a fastening member can be adopted as the sealing method of the inlet 2a, but the ease of sealing operation is easy. It is preferable to use a heat seal in view of reliability and the like.
  • the entrance 2a of the suppository container 2 is sealed by heat sealing, at least a portion of the entrance 2a of the suppository container 2 is made of a material which melts by heating to exhibit adhesiveness.
  • the inlet 2a of the suppository container 2 is sealed to form a seal portion 2a ', whereby the suppository package 5 according to the present invention is manufactured as shown in FIG. 2 (b). .
  • the space inside the suppository container 2 is densely filled with the filler 4
  • the filler 4 itself has a function as a sealing material, the hermeticity inside the suppository package 5 is completely maintained during storage and / or distribution.
  • the filler 4 is sealed in the suppository container 2 via the seal portion 2a, the filler 4 is used for the suppository.
  • the suppository container 2 can be more securely sealed by being integrated with the seal portion 2a 'of the container 2. Therefore, in the present embodiment, the contact between the suppository and the outside world can be completely cut off, so that the suppository 1 contained in the suppository container 2 is kept in a safe and good state until use. can do.
  • the suppository package 5 of the present embodiment Since there is no space in which the suppository 1 can move, even if the suppository 1 is melted when the suppository package 5 is kept at a temperature equal to or higher than the body temperature during the storage and / or distribution process, Suppository 1 does not move in container 2 for use. Therefore, the original shape of the suppository 1 can be maintained even when the suppository package 5 is turned over or turned upside down at a high temperature. Suppository 1 slightly increases in volume when melted, but this increase can be absorbed by the expansion of container 2.
  • the filler 4 since the filler 4 is integrated with the suppository container 2, even if the suppository container 2 is opened during use as shown in FIG. The filler 4 does not come off the suppository container 2. Therefore, when the user removes the suppository 1 from the suppository container 2, there is no danger that the filler 4 will be removed by mistake. Further, disposal of the suppository package after removing the suppository 1 is easy. In addition, since the filler 4 is fixed to the suppository container 2, the filler 4 does not move during storage or distribution, and does not affect the shape of the suppository 1. Example
  • the suppositories used in the examples were prepared by a conventional method. Table 1 shows the composition and properties. Next, 1.5 g of molten suppository was filled in a polypropylene suppository container having polyethylene laminated inside. After the suppository was solidified, 0.5 g of the melted polyvinyl acetate-based hot-melt adhesive was quickly filled thereon, and the suppository container inlet was immediately sealed with a heat sealer to seal the suppository package.
  • Table 1 Composition and properties of suppositories in Examples Drugs / Content (per one) Diflucortron valerate 0.2 mg Base powder
  • the suppository package of the present invention even if the suppository package is stored and / or circulated under a temperature condition equal to or higher than the body temperature and is turned over or turned upside down, the suppository is held in the suppository container. Is not deformed. When the flow starting temperature of the suppository is 50 ° C or more, deformation of the suppository can be more reliably prevented.
  • the suppository can be easily taken out of the container and the usability is improved.
  • the filler in the suppository container is fixed to the suppository container, there is no danger that the filler will accidentally remove the filler when removing the suppository from the suppository container. Subsequent disposal can be easily performed. Furthermore, the filler does not move in the suppository container, so it does not affect the shape of the suppository. In particular, when the filler is integrated with the seal portion of the suppository container, in addition to the above-described effects, the sealing of the seal portion becomes more reliable, and the suppository is shielded from the outside world, thereby providing a more secure Can be held.
  • the filler does not contain an eluting component, it is possible to prevent a chemical substance or the like that is not desirable for the human body from migrating to a suppository.
  • the filler is a hot-melt adhesive, integration with a suppository container and sealing can be easily performed.
  • the method of the present invention it is possible to obtain a suppository package in which the shape of the suppository is not lost even if the suppository is stored or distributed under a temperature condition equal to or higher than the body temperature and turned over or upside down.
  • a suppository and a filler are introduced into a container through the same container entrance, production of a suppository package becomes easier and work efficiency is improved.
  • the sealing portion can be more reliably sealed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)

Abstract

A novel suppository package free from a collapsed suppository shape even when preserved or distributed in a comparatively high-temperature environment, and a production method therefor. A suppository package (5) comprising a suppository (1) and a container (2) enclosing the suppository (1) therein, characterized in that a filler (4) is filled in the entire space between the suppository (1) and the container (2), the filler (4) preferably being fixed to the container (2).

Description

明細書 坐剤梱包体及びその製造方法 技術分野  Description Suppository package and manufacturing method thereof
本発明は坐剤本体がコンテナ内に包含された状態で保存又は流通過程におかれ る坐剤梱包体及びその製造方法に関し、 特に、 高温下での保存及び流通に好適な 坐剤梱包体及びその製造方法に関する。 背景技術  TECHNICAL FIELD The present invention relates to a suppository package and a method for producing the suppository package in which the suppository body is contained or stored in a container, and particularly to a suppository package suitable for storage and distribution at a high temperature. It relates to the manufacturing method. Background art
坐剤は室温では固体状態を保つが直腸内において体温により融解して薬物を放 出するので、 直腸粘膜から吸収させることが好ましい薬物の投与に広く使用され ている。  Suppositories remain in a solid state at room temperature, but melt in the rectum due to body temperature to release the drug. Therefore, suppositories are widely used for administration of drugs that are preferably absorbed through the rectal mucosa.
一般に、 坐剤は油脂性基剤に薬物等を添加混合して製造されており、 通常はプ ラスチック製の坐剤用コンテナによって梱包された坐剤梱包体として保存又は流 通過程に置かれている。 坐剤の融点は通常 3 0〜3 7 °C程度に設定されているの で、 坐剤梱包体は、 通常、 坐剤を溶融状態で坐剤用コンテナ内に注入した後に冷 却固化することによって製造されている。  In general, suppositories are manufactured by adding a drug or the like to an oily base, and are usually stored or passed through a suppository package packed in a plastic suppository container. I have. Since the melting point of suppositories is usually set at about 30 to 37 ° C, suppository packages should usually be cooled and solidified after the suppository is poured into the suppository container in a molten state. It is manufactured by.
ところで、 坐剤の保存及び/又は流通過程においては保冷、 並びに、 横転乃至 天地逆転の禁止が必須とされている。 これは、 体温以上の温度環境下で坐剤を保 存又は流通させると坐剤用コンテナ内で坐剤が溶融して、 その結果、 変形が生じ る恐れがあるからである。 特に、 坐剤用コンテナが横転又は天地逆転した状態で 周囲の温度が上昇して坐剤が溶融すると、 該コンテナ内で坐剤が移動して坐剤形 状が大きく変形する。 そして、 この状態で温度が低下すると、 変形したまま坐剤 が固化してしまうので商品価値が低下するのみならず、 直腸内への挿入が困難に なり使用不可となる場合もある。  By the way, in the storage and / or distribution process of suppositories, it is essential to keep cool and to prohibit rollover or upside down. This is because storing or distributing suppositories in a temperature environment equal to or higher than body temperature may cause the suppositories to melt in the suppository container, resulting in deformation. In particular, when the suppository melts due to an increase in ambient temperature while the suppository container is turned over or upside down, the suppository moves in the container and the suppository shape is greatly deformed. If the temperature drops in this state, the suppository will solidify as it is deformed, not only reducing the commercial value but also making it difficult to insert it into the rectum and making it unusable.
しかしながら、 これまでのところ、 いかに保冷並びに横転乃至天地逆転禁止を 心がけたとしても、 取扱者の過失乃至不可抗力等によって、 坐剤の変形を完全に 防止することは不可能であった。 ところで、 特閧昭 5 8 - 8 2 8 6 9号公報では、 坐剤用コンテナ内の空間に固 形の発泡プラスチックの小片を挿入して密封することが提案されている。しかし、 この方法であっても坐剤本体の変形を完全に防止することはできなかった。 しか も、 坐剤用コンテナ内の比較的狭い空間に適合した形状の発泡プラスチックの小 片を製造するには多くの付加工程を要し、 また、 当該小片をコンテナ内に挿入す るためには特殊な治具が必要となるので製造設備、 時間及びコストの面でも問題 があった。 さらに、 この方法では発泡プラスチックの小片はコンテナ内に坐剤と 共に単に封入されているので、 コンテナの開封時には小片がコンテナから外れ落 ちてしまう。 これは使用者に不安感を与えるだけでなく、 小片の廃棄のための余 分な手間をも必要としていた。 発明の開示 However, until now, it was impossible to completely prevent deformation of the suppository due to the negligence or force majeure of the handler, no matter how cold-keeping and prohibition of rollover or upside-down. By the way, Japanese Patent Publication No. 58-82869 proposes that a small piece of solid foamed plastic is inserted into a space in a suppository container and sealed. However, even with this method, deformation of the suppository body could not be completely prevented. However, the production of small pieces of foamed plastic that fits into a relatively small space in a suppository container requires many additional steps, and the insertion of the small pieces into the container requires Since special jigs were required, there were also problems in terms of manufacturing equipment, time and cost. Furthermore, in this method, the small pieces of foamed plastic are simply enclosed in the container together with the suppository, so that when the container is opened, the small pieces fall off the container. This not only caused anxiety to the user, but also required extra work to dispose of the small pieces. Disclosure of the invention
本発明は坐剤の保存乃至流通段階における上記した問題点を解決することをそ の課題とする。 すなわち、 本発明の目的は、 体温以上の温度環境下において保存 又は流通過程に置かれたとしても、 坐剤が変形することのない新規な坐剤梱包体 及びその製造方法を提供することにある。  An object of the present invention is to solve the above-mentioned problems in the storage or distribution stage of suppositories. That is, an object of the present invention is to provide a novel suppository package in which a suppository is not deformed even when stored or distributed in a temperature environment equal to or higher than body temperature, and a method for producing the same. .
本発明の坐剤梱包体は、 坐剤と、 前記坐剤を包含するコンテナとからなる坐剤 梱包体であって、 前記坐剤と前記コンテナとの間の空間の全てが充填材によって 封入されていることを特徴とする。 前記空間は前記坐剤の端部のみに隣接して存 在していてもよい。 ここで 「端部」 とは坐剤形状の長軸に沿った方向の端部を指 し、 坐剤本体の少なくとも一方の端部に隣接して充填されるべき空間が存在すれ ばよい。  The suppository package of the present invention is a suppository package comprising a suppository and a container containing the suppository, wherein the entire space between the suppository and the container is sealed with a filler. It is characterized by having. The space may exist adjacent only to the end of the suppository. Here, the “end” refers to the end in the direction along the long axis of the suppository, and it is sufficient that there is a space to be filled adjacent to at least one end of the suppository body.
本発明で用いられる充填材はその流動開始温度が 5 0 °C以上であることが好ま しい。 ここで 「流動開始温度」 とは充填材が溶融又は軟化して流動化を開始する 温度である。流動開始温度の具体的な値は充填材の材質及び測定方法に依存する。 例えば、充填材が低分子化合物及び結晶性高分子の場合は流動開始温度は融点(結 晶融点を含む) と同義であり、 J I S K 7 1 2 1に従って測定することができる。 また、 例えば充填材が非結晶性高分子の場合は、 流動開始温度は軟化温度と同義 であり、 例えば J I S K 7 2 0 6に従って測定することができる。 充填材はコンテナと固着されていることが好ましい。 特に、 当該コンテナがシ 一ル部を備えている場合は、 前記充填材は当該シール部と一体化されていること がより好ましい。 The filler used in the present invention preferably has a flow start temperature of 50 ° C. or higher. Here, the “flow start temperature” is a temperature at which the filler starts melting and softening to start fluidization. The specific value of the flow start temperature depends on the material of the filler and the measuring method. For example, when the filler is a low molecular compound or a crystalline polymer, the flow onset temperature is synonymous with the melting point (including the crystal melting point), and can be measured according to JISK7121. Further, for example, when the filler is an amorphous polymer, the flow start temperature has the same meaning as the softening temperature, and can be measured, for example, according to JISK720. Preferably, the filler is fixed to the container. In particular, when the container has a seal portion, the filler is more preferably integrated with the seal portion.
本発明の坐剤梱包体においては、充填材が溶出成分を含まないことが好ましく、 とりわけ、 前記充填材がホッ トメルト型接着剤であることが好ましい。 なお、 前 記 「溶出成分」 とは、 何らかの作用乃至条件下において充填材から該充填材の外 部へ溶出するあらゆる物質を指す。  In the suppository package of the present invention, it is preferable that the filler does not contain an eluted component, and it is particularly preferable that the filler is a hot melt adhesive. The “eluting component” mentioned above refers to any substance that elutes from the filler to the outside of the filler under any action or condition.
本発明の坐剤梱包体の製造方法は、 坐剤をコンテナ入口よりコンテナの内部に 導入する導入工程と、 前記坐剤と前記コンテナとの間の空間に流動状の充填材を 充填する充填工程と、 前記コンテナ入口をシールする封止工程とを含むことを特 徴とする。 前記導入工程は、 流動状の坐剤をコンテナ内に注入する工程及び当該 坐剤を固化させる工程とを含んでもよい。 前記充填工程における充填は前記コン テナ入口を介して行われることが好ましく、 さらに、 前記コンテナ入口は前記充 填材と共にシールされることが好ましい。  The method for producing a suppository package of the present invention includes: an introduction step of introducing a suppository from the container entrance into the interior of the container; and a filling step of filling a space between the suppository and the container with a fluid filler. And a sealing step of sealing the container entrance. The introduction step may include a step of injecting a fluid suppository into the container and a step of solidifying the suppository. The filling in the filling step is preferably performed via the container inlet, and the container inlet is preferably sealed together with the filler.
本発明の製造方法においても、 充填材の流動開始温度は 5 0 °C以上であること が好ましい。 また、 充填材は溶出成分を含まないことが好ましく、 とりわけ、 前 記充填材がホッ トメルト型接着剤であることが好ましい点も同様である。 本発明 は上記したこれらの製造方法によって製造された坐剤梱包体をも含む。  Also in the production method of the present invention, the flow start temperature of the filler is preferably 50 ° C. or higher. Further, it is preferable that the filler does not contain an eluted component, and in particular, it is preferable that the filler is a hot-melt adhesive. The present invention also includes a suppository package produced by the above-mentioned production methods.
本発明の他の形態は、 坐剤及び当該坐剤を包含するコンテナとからなる坐剤梱 包体において、 当該コンテナ内の空間に流動状の充填材を充填することを含む坐 剤の変形防止方法である。 この形態においても充填材の流動開始温度は 5 0 °C以 上であることが好ましい。 図面の簡単な説明  Another aspect of the present invention relates to a suppository package comprising a suppository and a container containing the suppository, wherein the suppository is deformed by filling a space in the container with a fluid filler. Is the way. Also in this embodiment, the flow start temperature of the filler is preferably 50 ° C. or higher. BRIEF DESCRIPTION OF THE FIGURES
図 1 従来タイプの坐剤梱包体及びその製造過程を示す縦断面図である。 図 2 本発明に係る坐剤梱包体及びその製造方法の一実施の形態を示す縦断面 図である。  FIG. 1 is a longitudinal sectional view showing a conventional suppository package and a manufacturing process thereof. FIG. 2 is a longitudinal sectional view showing one embodiment of a suppository package and a method for producing the same according to the present invention.
図 3 本発明の坐剤梱包体の開封状態を示す縦断面図である。 発明の詳細な説明 FIG. 3 is a longitudinal sectional view showing the opened state of the suppository package of the present invention. Detailed description of the invention
本発明者は、 坐剤が保存又は流通過程において体温以上の高温にさらされたと きに変形するメカニズムについて詳細に研究したところ、坐剤の変形は、坐剤と、 該坐剤を包含する坐剤用コンテナとの間の空隙の存在に起因することを突き止め た。 すなわち、 内部に空隙が存在するコンテナ内で坐剤が溶融した場合に該コン テナが横転又は天地逆転すると、 該空隙部に坐剤が移動して元の坐剤の形状が変 形してしまい、 この状態で温度が降下すると、 変形したままの状態で坐剤が硬化 するのである。  The present inventors have studied in detail the mechanism by which a suppository deforms when exposed to a high temperature of body temperature or higher during the storage or distribution process, and found that the suppository is deformed by a suppository and a suppository including the suppository. It was found that this was caused by the existence of a gap between the agent container. In other words, if the suppository melts in a container with a void inside and the container rolls over or reverses, the suppository moves into the void and the original suppository deforms. However, if the temperature drops in this state, the suppository will harden in the deformed state.
ここで、 図面を参照して坐剤用コンテナ内の空隙の発生及び当該空隙の存在に 基づく坐剤の変形機構について詳細に説明する。 図 1は従来のタイプの坐剤梱包 体及びその製造過程を示す縦断面図であり、 図 1 ( a)は坐剤 1が所定量だけ充填 された、 シール前の坐剤用コンテナ 2を示す。 一方、 図 1 ( b )は図 1 ( a )における X— X線に沿って坐剤用コンテナ 2の入口 2 aをシールした状態を示す。  Here, the generation of voids in the suppository container and the deformation mechanism of the suppository based on the presence of the voids will be described in detail with reference to the drawings. FIG. 1 is a longitudinal sectional view showing a conventional type of suppository package and its manufacturing process, and FIG. 1 (a) shows a suppository container 2 before sealing, filled with a predetermined amount of a suppository 1. . On the other hand, FIG. 1 (b) shows a state where the entrance 2a of the suppository container 2 is sealed along the line X-X in FIG. 1 (a).
従来のタイプの坐剤梱包体は、 図 1に示すように、 坐剤用コンテナ 2内に高温 の溶融した坐剤 1を導入し、 次いで室温で冷却して坐剤 1を固化させ、 その後、 坐剤用コンテナ 2の入口 2 aをシールすることによって製造されている。 なお、 坐剤用コンテナ 2内の坐剤 1は固化時に収縮するので一般にその表面の中央部が 陥没したような形状となる。  As shown in Fig. 1, a conventional type of suppository package is to introduce a high-temperature molten suppository 1 into a suppository container 2 and then cool it at room temperature to solidify the suppository 1, followed by It is manufactured by sealing the entrance 2a of the suppository container 2. The suppository 1 in the suppository container 2 shrinks when it solidifies, so that the suppository 1 generally has a shape in which the center of the surface is depressed.
図 1から明らかなように、 坐剤用コンテナ 2内の空間を坐剤 1が完全に満たさ ない状態でその入口 2 aをシールすると、 必然的に坐剤用コンテナ 2内に空隙 3 が形成される。 冷却状態では坐剤 1は流動化しないので空隙 3の存在は特に問題 とはならない。 しかし、 高温環境下ではコンテナ内の坐剤 1は溶融して流動状態 となる。 したがって、 この状態でコンテナ 2が横転又は天地逆転すると、 坐剤 1 は空隙 3へ移動してしまう。 そして、 コンテナ 2が横転又は天地逆転したままの 状態で周囲の温度が低下すると坐剤 1はそのまま硬化して、 その形状が変化する のである。  As is evident from FIG. 1, when the space inside the suppository container 2 is not completely filled with the suppository 1 and the inlet 2a is sealed, a space 3 is inevitably formed in the suppository container 2. You. Since the suppository 1 does not fluidize in the cooled state, the presence of the void 3 does not cause any particular problem. However, in a high temperature environment, the suppository 1 in the container melts and becomes fluid. Therefore, if the container 2 rolls over or turns upside down in this state, the suppository 1 moves to the gap 3. When the temperature of the surroundings is reduced while the container 2 is still turned over or turned upside down, the suppository 1 is hardened as it is, and its shape changes.
このように、 坐剤の変形の原因はコンテナ内に自由空間が存在することである から、 坐剤の変形を防止するためにはコンテナ内の空間の発生を回避することが 好ましい。 したがって、 例えば図 1の例では、 コンテナ 2内の空隙 3の発生を回 避するために、 坐剤梱包体の製造にあたって坐剤用コンテナ 2内の全ての空間に 坐剤 1を密に充填することが考えられる。 As described above, since the suppository is deformed due to the existence of free space in the container, it is preferable to avoid the space in the container in order to prevent the suppository from being deformed. Therefore, for example, in the example of FIG. In order to avoid this, it is conceivable that all the spaces in the suppository container 2 are densely filled with the suppository 1 in the manufacture of the suppository package.
しかしながら、図 1において、坐剤用コンテナ 2内に坐剤 1を密に充填すると、 入口 2 aをシールして製品とする際に坐剤 1を挟み込んだ状態で入口 2 aがシー ルされてしまい、 坐剤用コンテナ 2のシールが不完全となる問題が新たに発生す 一方、 坐剤 1を密に充填することなく、 図 1 ( a)において Y— Y線に沿って坐 剤用コンテナ 2の入口 2 aをシールした場合も、 たしかに空隙 3の容積は減少す るが、 やはり入口 2 aが坐剤 1の一部を挟み込んで坐剤用コンテナ 2のシールが 不完全となる恐れがある。 仮に、 坐剤 1の挟み込みが無い状態で Y— Y線に沿つ て坐剤用コンテナ 2をシールできたとしても、 溶融状態にある坐剤 1が固化する 際にその端部表面が凹状に陥没することは避けられないので、 坐剤用コンテナ 2 内の一部に空隙が残存することは避けられない。  However, in FIG. 1, when the suppository 1 is densely filled in the suppository container 2, the entrance 2a is sealed with the suppository 1 sandwiched when the entrance 2a is sealed to form a product. This causes a new problem that the seal of the suppository container 2 is incomplete.On the other hand, the suppository container is not filled tightly with the suppository 1 but along the line Y--Y in FIG. 1 (a). Even if the inlet 2a of 2 is sealed, the volume of the cavity 3 will certainly decrease, but again the inlet 2a may sandwich a part of the suppository 1 and the sealing of the suppository container 2 may be incomplete. is there. Even if the suppository container 2 could be sealed along the line Y--Y without the suppository 1 being pinched, the end surface of the suppository 1 would be concave when the molten suppository 1 solidified. Since it is inevitable to collapse, it is inevitable that voids remain in a part of the suppository container 2.
すなわち、 図 1に示すような坐剤梱包体を従来の方法で製造する場合、 坐剤 1 の挟み込みを防いでコンテナ 2の入口 2 aのシールを完全とする点ではコンテナ 2内の空隙 3は必須であり、 しかもその容積はできるだけ大きい方が好ましいの である。 したがって、 コンテナ 2内の坐剤 1の変形を防止するという点ではコン テナ 2内の空隙 3を排除すべきであるにもかかわらず、 従来の製造方法では、 坐 剤 1を坐剤用コンテナ 2に密に充填することはコンテナ 2のシール性の点からみ て実施できない。 - そこで、 本発明者は、 坐剤用コンテナ内に空隙が発生することなく、 かつ、 該 コンテナのシールを完全に実施できる新規な坐剤梱包体及びその製造方法につい て鋭意検討した結果、 坐剤と坐剤用コンテナ内面との間の空間に流動状の充填材 を封入させた状態で該コンテナ入口をシールする方法が有用であることを見出し た。  In other words, when a suppository package as shown in FIG. 1 is manufactured by a conventional method, the gap 3 in the container 2 is such that the suppository 1 is prevented from being pinched and the seal of the inlet 2 a of the container 2 is completed. It is essential, and it is preferable that the volume is as large as possible. Therefore, in order to prevent deformation of the suppository 1 in the container 2, the void 3 in the container 2 should be eliminated in order to prevent the deformation of the suppository 1 in the container 2. It is not feasible to densely fill the container 2 in view of the sealing property of the container 2. -Accordingly, the present inventor has conducted intensive studies on a novel suppository package and a method for producing the suppository package which can completely seal the container without generating a void in the suppository container. It has been found that a method of sealing the entrance of the container with the fluid filler filled in the space between the suppository and the inner surface of the suppository container has been found to be useful.
図 2は本発明に係る坐剤梱包体 5及びその製造方法の一実施の形態を示す縦断 面図であり、 図 2 ( a)は坐剤用コンテナ 2の入口 2 aがシールされる前の状態を 示す。 一方、 図 2 ( b )は図 2 ( a )における X— X線に沿って坐剤用コンテナ 2の入 口 2 aを後述するように充填材 4と共にシールし、 シール部 2 a ' とした本発明 o FIG. 2 is a longitudinal sectional view showing an embodiment of a suppository package 5 and a method for producing the suppository package according to the present invention, and FIG. 2 (a) shows a state before an entrance 2a of a suppository container 2 is sealed. Indicates the status. On the other hand, in FIG. 2 (b), the entrance 2a of the suppository container 2 is sealed together with the filler 4 as described later along the line X--X in FIG. 2 (a) to form a seal portion 2a '. The present invention o
の坐剤梱包体 5を示す。 5 shows a suppository package 5 of the present invention.
図 2に示す実施の形態では、 坐剤用コンテナ 2は同一形状の凹部を有する 2枚 のシートが該凹部を向かい合わせた状態で貼り合わされて構成されており、 該凹 部によって形成される空間内に坐剤 1が保持される。 ただし、 前記シートの一部 は相互に貼り合わされず、 前記空間への入口 2 aを構成する。 なお、 コンテナ 2 によって形成される空間の形状は特に限定されるものではないが、 坐剤 1の使用 を容易とするためには、 図示されるような、 長軸 Zを有する略紡錘形であること が好ましい。  In the embodiment shown in FIG. 2, the suppository container 2 is formed by bonding two sheets having the same shape of a concave portion with the concave portion facing each other, and a space formed by the concave portion. Suppository 1 is held in it. However, a part of the sheets is not bonded to each other, and forms an entrance 2a to the space. The shape of the space formed by the container 2 is not particularly limited, but in order to facilitate the use of the suppository 1, the space must be substantially spindle-shaped with a long axis Z as shown in the figure. Is preferred.
坐剤用コンテナ 2の材質は特に限定されるものではなく、例えばポリェチレン、 ポリプロピレン、 ポリ塩化ビニル、 ポリスチレン、 ポリエステル等の汎用の合成 樹脂材料等を使用することが可能であるが、 ヒートシール可能な点では、 ポリエ チレン、ポリプロピレン等のポリオレフィン系の合成樹脂材料が好ましい。また、 坐剤用コンテナ 2を構成するシートは複数の異なる材質からなるシートの積層体 であってもよい。  The material of the suppository container 2 is not particularly limited, and for example, a general-purpose synthetic resin material such as polyethylene, polypropylene, polyvinyl chloride, polystyrene, or polyester can be used. In this respect, polyolefin-based synthetic resin materials such as polyethylene and polypropylene are preferable. Further, the sheets constituting the suppository container 2 may be a laminate of sheets made of a plurality of different materials.
本発明においては、 坐剤用コンテナ 2に保持される坐剤 1の基剤及びそこに配 合される薬剤の種類は特に限定されない。前記基剤としては、例えばカプリル酸、 力プリン酸、 ペラゴン酸、 ゥンデシル酸、 トリデシル酸、 ラウリン酸、 ミリスチ ン酸、 ノ レミチン酸、 ペン夕デシル酸、 ヘプ夕デシル酸、 ステアリン酸、 ォレイ ン酸、 エライジン酸、 リノール酸、 リノレイン酸等の不飽和脂肪酸又は不飽和脂 肪酸グリセリンエステルを挙げることができる。 これらは必要に応じて 1種又は 2種以上を適宜混合して使用することができ、 また、 通常は不飽和又は飽和脂肪 酸とグリセリンとのモノ、 ジ及びトリエステルの混合物が好ましい。  In the present invention, the type of the base of the suppository 1 held in the suppository container 2 and the type of the drug to be mixed therewith are not particularly limited. Examples of the base include caprylic acid, capric acid, pelagonic acid, pendecylic acid, tridecylic acid, lauric acid, myristic acid, noremitic acid, penicillic acid, heptamine decylic acid, stearic acid, and oleic acid. And unsaturated fatty acids such as elaidic acid, linoleic acid and linoleic acid, and unsaturated fatty acid glycerin esters. These can be used alone or in admixture of two or more, if necessary. Usually, a mixture of mono-, di- and triesters of unsaturated or saturated fatty acid and glycerin is preferable.
前記基剤には、 非イオン性界面活性剤、 カチオン性界面活性剤又はァニオン性 界面活性剤の 1種又は 2種以上を添加することが可能であるが、 坐剤 1の溶融液 の分散安定性等の点では、 グリセリン脂肪酸エステル、 プロピレングリコール脂 肪酸エステル、 ソルビ夕ン脂肪酸エステル、 ポリオキシエチレンソルビ夕ン脂肪 酸エステル、 ポリオキシエチレン脂肪酸エステル、 ポリオキシエチレン脂肪酸ァ ルコールエーテル、 ポリオキシエチレンアルキルフエニルエーテル、 ポリオキシ エチレンヒマシ油等の非イオン性界面活性剤を使用することが好ましい。 坐剤 1の硬度又は使用感、 並びに、 坐剤 1からの薬物の放出性及び安定性を改 善するために、 前記基剤には油性成分を添加することが好ましい。 前記油性成分 としては、 ゴマ油、 ォリーブ油、 ツバキ油、 ダイズ油、 ナタネ油、 綿実油、 アマ 二油、 ヒマシ油、 ヌカ油、 トウモロコシ油、 落花生油、 ヤシ油、 ァ一モン ド油、 ァボガード油、 パーム油、 パ一ム核油、 カャ油、 力ホック油、 クロモジ油、 サザ ンカ油、 チヤ油、 エノ油、 カカオ脂、 二ヅケィ脂、 ラウリン脂、 牛脂、 豚脂、 羊 毛脂、 タートル油、 スクワレン等の動植物油脂や、 これらの動植物油脂を水素添 加、 脂肪酸変換、 ァセチル化、 分割抽出等により化学的に変化させて得られる改 質油脂、 ヮセリン、 白色ヮセリン、 流動パラフィン、 パラフィ ン、 脱水ラノ リン、 ァイソバー、 シリコン脂等の鉱物油、 イソプロビルミリステート、 ノルマルプチ ルミ リステート、 イソプロビルリノ レート、 ステアリルリノレート、 ジェチルセ バケ一ト、 ジイソプロビルアジべート、 セチルアルコール、 ステアリルアルコー ル、 サラシミツロウ、 ゲイロウ、 モクロウ等の高級脂肪族アルコール、 高級脂肪 酸エステル、 ワックス類、 ステアリン酸、 ォレイン酸、 パルミチン酸等の高級脂 肪酸等が挙げられる。 これらは必要に応じて 1種又は 2種以上を混合して使用し てもよい。 One or more of a nonionic surfactant, a cationic surfactant and an anionic surfactant can be added to the base, but the dispersion of the melt of the suppository 1 is stable. In terms of properties, etc., glycerin fatty acid ester, propylene glycol fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene fatty acid ester, polyoxyethylene fatty acid alcohol ether, polyoxyethylene It is preferable to use a nonionic surfactant such as alkyl phenyl ether and polyoxyethylene castor oil. In order to improve the hardness or feeling of use of the suppository 1 and the release and stability of the drug from the suppository 1, it is preferable to add an oil component to the base. The oleaginous components include sesame oil, olive oil, camellia oil, soybean oil, rapeseed oil, cottonseed oil, linseed oil, castor oil, nuka oil, corn oil, peanut oil, coconut oil, fragrant oil, avogard oil, Palm oil, palm kernel oil, cocoa oil, royal hook oil, kuromoji oil, sazanka oil, charcoal oil, eno oil, cocoa butter, 20 cay fat, laurin fat, beef fat, lard, wool fat, turtle oil , Squalene, etc., and modified fats and oils obtained by chemically changing these animal and vegetable fats and oils by hydrogenation, fatty acid conversion, acetylation, fractional extraction, etc., cerin, white cerin, liquid paraffin, paraffin, Mineral oils such as dehydrated lanolin, silicone bars, silicone grease, isopropylvir myristate, normal butylmilystate, isopropylylinolate Higher fatty alcohols such as stearyl linoleate, getylse bucket, diisopropyl adipate, cetyl alcohol, stearyl alcohol, salami beeswax, gay wax, mocrowe, higher fatty acid esters, waxes, stearic acid, oleic acid And higher fatty acids such as palmitic acid. These may be used alone or as a mixture of two or more as necessary.
坐剤 1に配合される薬物は治療等の対象に応じて適宜選択されるが、 例えば、 ジクロフエナックナトリウム、 ピロキシカム、 ァセトァミノフェン、 インドメ夕 シン、 ケ トプロフェン、 塩酸ブプレノルフィ ン、 イブプロフェン、 アスピリン等 の解熱鎮痛消炎剤、 吉草酸ジフルコルトロン、 酢酸ヒ ドロコルチドン、 ベタメ夕 ゾン等の副腎皮質ホルモン剤、 塩酸モルヒネ等のあへんアルカロイ ド系麻薬、 ド ンペリゾン等の消化器官用剤、 テガフール、 フルォロウラシル等の代謝拮抗剤、 ゲメプロスト等のホルモン剤、 ジァゼパム、 フエノバルビタール等の催眠鎮静剤 '抗不安剤、 ビザコジル等の下剤 '浣腸剤、 サラゾスルフアビリジン等のサルフ ァ剤、 セフチヅキシムナトリウム等の抗生物質、 アミノフィ リン等の気管支拡張 剤、 トリべノシド、 プロク トセディル、 大腸菌死菌、 シコンエキス、 ロートェキ ス等の痔疾用剤が挙げられる。 坐剤 1には必要に応じて、 局所麻酔薬、 抗ヒス夕 ミン剤、 殺菌剤、 ビタミン剤、 アミノ酸類、 胆汁酸類等の薬物を更に添加しても よい。 さらに、 坐剤 1には必要に応じて他の補助成分を添加することもできる。 o The drug to be incorporated in suppository 1 is appropriately selected depending on the target of treatment and the like. For example, diclofenac sodium, piroxicam, acetaminophen, indomethacin, ketoprofen, buprenorphine hydrochloride, ibuprofen, aspirin Antipyretic analgesics and anti-inflammatory drugs, such as diflucortron valerate, hydrocortidone acetate, betamethasone, etc., corticosteroids such as morphine hydrochloride, alkaloid drugs such as morphine hydrochloride, drugs for digestive organs such as domperisone, tegafur, fluorouracil Antimetabolites such as gemprost; sedatives such as diazepam and phenobarbital; sedatives such as anxiolytics and visacodyl; enemas; sulphas such as salazosulfaviridine; ceftidixim sodium; Bronchodilation of antibiotics, aminophylline, etc. Agents, tribenoside, protosedil, killed bacteria of Escherichia coli, sicon extract, rotoex, and the like. Suppository 1 may further contain a drug such as a local anesthetic, an anti-histamine, a bactericide, a vitamin, an amino acid, or a bile acid, if necessary. Further, other auxiliary ingredients can be added to the suppository 1 as needed. o
前記補助成分としては水、 安定化剤、 保存剤、 着色剤、 芳香剤、 分散剤、 増粘剤、 p H調節剤、 湿潤剤、 抗酸化剤、 防腐剤、 賦形剤等が挙げられる。 本実施の形態における坐剤梱包体 5は以下のようにして製造される。 Examples of the auxiliary component include water, a stabilizer, a preservative, a coloring agent, a fragrance, a dispersant, a thickener, a pH regulator, a wetting agent, an antioxidant, a preservative, and an excipient. The suppository package 5 in the present embodiment is manufactured as follows.
まず、 坐剤用コンテナ 2の入口 2 aを鉛直上方に開口させた状態で、 図示しな いノズルを介して溶融状態の坐剤 1が坐剤用コンテナ 2内の空間に導入される。 坐剤 1は坐剤用コンテナ 2内の空間に完全には充填されず、 その底部からある程 度の高さまで充填される。その後、 坐剤 1は室温で冷却されて固化される。なお、 コンテナ 2内の形状に合致した表面形状を有する固形の坐剤 1を予め別工程で作 製しておき、 それをコンテナ 2内に挿入して坐剤 1をコンテナ 2内に導入しても よい。  First, with the inlet 2a of the suppository container 2 opened vertically upward, the suppository 1 in a molten state is introduced into the space in the suppository container 2 via a nozzle (not shown). The suppository 1 is not completely filled in the space in the suppository container 2 but is filled to a certain height from the bottom. Thereafter, the suppository 1 is cooled and solidified at room temperature. In addition, a solid suppository 1 having a surface shape matching the shape of the container 2 is prepared in advance in a separate process, inserted into the container 2, and the suppository 1 is introduced into the container 2. Is also good.
次に、 図示しない供給手段を介して流動状の充填材 4が坐剤用コンテナ 2に残 存する空間に密に充填される。 充填材 4の前記空間への充填経路は特に制限され ないが、 作業効率上は入口 2 aから充填されることが好ましい。  Next, the space remaining in the suppository container 2 is densely filled with the fluid filler 4 via a supply means (not shown). The filling path of the filler 4 into the space is not particularly limited, but it is preferable that the filler 4 is filled from the inlet 2a in terms of working efficiency.
坐剤 1の表面全体が充填材 4によって包囲され、 坐剤 1の使用が困難となるこ とを回避するために、 充填材 4で充填されるべきコンテナ 2内の空間は坐剤 1の 長軸 Zに沿った端部のみに隣接して存在していることが好ましい。 また、 充填材 4の充填の容易性の点では、 充填材 4が充填されるべき空間は、 図 2に示すよう に、 コンテナ 2の入口 2 aに近い側の坐剤 1の端部に隣接して存在することが好 ましい。  In order to avoid that the entire surface of the suppository 1 is surrounded by the filler 4 and that it becomes difficult to use the suppository 1, the space in the container 2 to be filled with the filler 4 is the length of the suppository 1. It is preferably present only adjacent to the end along the axis Z. In addition, in terms of ease of filling with the filling material 4, the space to be filled with the filling material 4 is adjacent to the end of the suppository 1 near the entrance 2a of the container 2, as shown in FIG. It is preferable that they exist.
コンテナ 2内の坐剤 1が固化すると坐剤 1の表面は各コンテナ毎に様々な形状 に陥没するので、 特開昭 5 8 - 8 2 8 6 9号公報に記載されるようなコンテナ 2 内の空間に一定形状の固形のプラスチック小片を挿入する方法ではコンテナ 2内 に坐剤 1の変形の原因となる空隙が残留することは避けられないが、 本実施の形 態では流動状の充填材 4を用いるので、 坐剤 1が固化する際に生じる端部表面の 凹状陥没部分の形状にかかわらず、 コンテナ 2内の空間は完全に充填材 4によつ て満たされる。 したがって、 坐剤用コンテナ 2内に空隙が残存することがない。 充填材 4の材質は特に制限されるものではないが、 坐剤梱包体の保存及び/又 は流通過程に起こりうる高温環境下であっても固体形状を維持する物質であるこ とが好ましい。 したがって、 具体的には、 充填材 4の流動開始温度は 5 0 °C以上 が好ましく、 7 0 °C以上がより好ましく、 9 0 °C以上が最も好ましい。 5 0 °C未 満では坐剤梱包体の保存及び/又は流通過程において充填材 4が溶融して坐剤 1 と一体化するおそれがある。 一方、 充填材 4の流動開始温度が高すぎると、 坐剤 用コンテナ 2内への導入時に充填材 4が坐剤 1を熱変質等させるおそれがあるの で、 充填材 4の流動開始温度は 1 5 0 °C以下が好ましく、 1 3 0 °C以下がより好 ましく、 最も好ましくは 1 1 0 °C以下である。 When the suppository 1 in the container 2 solidifies, the surface of the suppository 1 sinks into various shapes for each container, so the inside of the container 2 as described in JP-A-58-82869 is disclosed. Although it is inevitable that voids causing deformation of the suppository 1 remain in the container 2 by the method of inserting solid plastic pieces of a certain shape into the space of the present embodiment, in the present embodiment, the fluid filler Since the suppository 1 is used, the space in the container 2 is completely filled with the filler 4 irrespective of the shape of the concave depression on the end surface generated when the suppository 1 solidifies. Therefore, no void remains in the suppository container 2. The material of the filler 4 is not particularly limited, but it must be a substance that maintains a solid shape even in a high-temperature environment that may occur in the storage and / or distribution process of the suppository package. Is preferred. Therefore, specifically, the flow start temperature of the filler 4 is preferably 50 ° C. or higher, more preferably 70 ° C. or higher, and most preferably 90 ° C. or higher. If the temperature is lower than 50 ° C, the filler 4 may be melted and integrated with the suppository 1 during the storage and / or distribution of the suppository package. On the other hand, if the flow start temperature of the filler 4 is too high, the filler 4 may cause thermal deterioration of the suppository 1 when introduced into the suppository container 2, so that the flow start temperature of the filler 4 The temperature is preferably 150 ° C. or lower, more preferably 130 ° C. or lower, and most preferably 110 ° C. or lower.
流動状態にある充填材 4の物理的性状は、 坐剤用コンテナ 2内の空間を完全に 充填して坐剤 1の移動を阻止するものであれば特に限定されるものではなく、 液 体状又はペース ト状等であってもよい。 ただし、 坐剤用コンテナ 2内への導入の 容易性及び坐剤用コンテナ 2のシールの容易性の点では、 加熱等の手段によって 充填材 4の粘度が制御できることが好ましい。  The physical properties of the filler 4 in a fluid state are not particularly limited as long as the space in the suppository container 2 is completely filled and the suppository 1 is prevented from moving. Or it may be in a paste form or the like. However, in view of the ease of introduction into the suppository container 2 and the ease of sealing the suppository container 2, it is preferable that the viscosity of the filler 4 can be controlled by means such as heating.
上記の好ましい特性を満たす充填材 4の材質としては、 例えば、 合成及び/又 は天然の高分子材料が挙げられる。 充填材 4を合成又は天然高分子材料から構成 する場合は、 コンテナ 2への接着性、 入口 2 aのシール性等の点でホッ トメルト 型接着剤を用いることが特に好ましい。 本発明におけるホッ トメルト型接着剤と しては、 加熱により溶融して接着性を発揮し冷却により固化して接着状態を維持 するものの他にいわゆる反応性ホッ トメル卜型接着剤を使用することができる。 そのようなホッ トメルト型接着剤としては、 例えば、 ポリエチレン、 ポリプロピ レン、 ポリィソプチレン等のォレフィン樹脂系接着剤、 ポリィソブチレンポリア ミ ド、 ナイロン— 1 1、 ナイロン一 1 2等のポリアミ ド系接着剤、 ァクリル樹脂 系接着剤、 ポリ酢酸ビニル系接着剤、 ポリエステル系接着剤、 ポリビニルブチラ —ル等のポリビニルァセタール系接着剤、 エチレン—酢酸ビニル共重合体系接着 剤、 熱可塑性エラストマ一系接着剤、 ウレタン系反応性ホッ トメルト接着剤等が 挙げられるが、 人体に有害な溶出成分を含まないものであることが好ましい。 充填材 4は坐剤 1と接触するので、 人体に好ましくない成分が坐剤 1へ移行す ることを防止するために、 充填材 4の材質は、 水、 有機溶媒、 重合開始剤、 架橋 剤、 未重合のモノマー等の各種の成分の溶出が無いか、 又は、 あってもきわめて 少ないものとすることが好ましい。 坐剤 1の形状保持性及び開封時の取り扱いの簡易性等の観点からは、 充填材 4 は坐剤用コンテナ 2に対して固着されていることが好ましい。 充填材 4と坐剤用 コンテナ 2との固着方法としては、 充填材 4の少なくとも一部を接着剤を用いて 坐剤用コンテナ 2に接着する態様等を挙げることができるが、 製造工程の簡略化 の点で、 充填材 4自体を坐剤用コンテナ 2に対して付着性乃至接着性を有する材 質によって構成することが好ましい。 ただし、 その場合には、 充填材 4を構成す る材質は坐剤 1に対しては付着乃至接着しないことが好適である。 Examples of the material of the filler 4 that satisfies the above preferable characteristics include synthetic and / or natural polymer materials. When the filler 4 is composed of a synthetic or natural polymer material, it is particularly preferable to use a hot-melt adhesive in view of adhesiveness to the container 2 and sealing of the inlet 2a. As the hot-melt adhesive in the present invention, a so-called reactive hot-melt adhesive may be used, in addition to one that melts by heating to exhibit adhesiveness and solidifies by cooling to maintain an adhesive state. it can. Examples of such hot melt type adhesives include, for example, polyethylene resin, polypropylene, and polyolefin resin-based adhesives, polybutylene polyamide, polyamide-based adhesives such as nylon-11, nylon-11, and the like. , Acryl resin adhesives, polyvinyl acetate adhesives, polyester adhesives, polyvinyl acetal adhesives such as polyvinyl butyral, ethylene-vinyl acetate copolymer adhesives, thermoplastic elastomer adhesives And urethane-based hot-melt adhesives, etc., but preferably do not contain elution components harmful to the human body. Filler 4 comes in contact with suppository 1, so the material of filler 4 should be water, organic solvent, polymerization initiator, cross-linking agent in order to prevent undesired components from migrating to suppository 1. It is preferred that various components such as unpolymerized monomers are not eluted, or at least very little. It is preferable that the filler 4 is fixed to the suppository container 2 from the viewpoints of the shape retention of the suppository 1 and the easiness of handling at the time of opening. Examples of a method of fixing the filler 4 to the suppository container 2 include a mode in which at least a part of the filler 4 is adhered to the suppository container 2 using an adhesive, but the manufacturing process is simplified. From the viewpoint of formation, it is preferable that the filler 4 itself be made of a material having adhesiveness or adhesiveness to the suppository container 2. However, in this case, it is preferable that the material constituting the filler 4 does not adhere to or adhere to the suppository 1.
本実施の形態においては、 図 2 ( a)に示されるように、 充填材 4が坐剤 1 と坐 剤用コンテナ 2との間の空間に完全に充填されると、 同図の X— X線に沿って坐 剤用コンテナ 2の入口 2 aがシールされる。 入口 2 aのシール方法としては、 接 着剤による封止、 加熱手段との接触乃至押圧によるヒートシール、 締結部材によ る閉止等の様々な方法が採用可能であるが、 シール操作の容易性及び確実性等の 点でヒートシールとすることが好ましい。 なお、 坐剤用コンテナ 2の入口 2 aを ヒートシールによって封止する場合には、 坐剤用コンテナ 2の少なくとも入口 2 aの部分は、加熱により溶融して接着性を発揮する材質とされている必要がある。 そして最後に、 坐剤用コンテナ 2の入口 2 aがシールされてシール部 2 a ' と なることにより、 図 2 (b )に示すように、 本発明に係る坐剤梱包体 5が製造され る。 本実施の形態では、 坐剤用コンテナ 2内の空間には充填材 4が密に充填され ているので、 入口 2 aのシール時には、 充填材 4の一部がシール部分に挟み込ま れ、 共にシールされうるが、 ここでは充填材 4自体がシール材としての機能を有 しているために、 坐剤梱包体 5内部の密封性は保存及び/又は流通過程において 完全に維持される。 すなわち、 このようにして製造された坐剤梱包体 5において は、 充填材 4がシール部 2 a, を介して坐剤用コンテナ 2内に封入されているの で、 充填材 4は坐剤用コンテナ 2のシール部 2 a ' と一体化して、 坐剤用コンテ ナ 2のシールをより確実なものとすることができる。 したがって、 本実施の形態 では坐剤と外界との接触を完全に断つことが可能となるので、 坐剤用コンテナ 2 の内部に収容された坐剤 1を使用時まで安全かつ良好な状態で保持することがで きる。  In the present embodiment, as shown in FIG. 2 (a), when the filler 4 is completely filled in the space between the suppository 1 and the suppository container 2, X—X in FIG. Along the line, the entrance 2a of the suppository container 2 is sealed. Various methods such as sealing with an adhesive, heat sealing by contact or pressing with a heating means, and closing with a fastening member can be adopted as the sealing method of the inlet 2a, but the ease of sealing operation is easy. It is preferable to use a heat seal in view of reliability and the like. When the entrance 2a of the suppository container 2 is sealed by heat sealing, at least a portion of the entrance 2a of the suppository container 2 is made of a material which melts by heating to exhibit adhesiveness. Need to be. Finally, the inlet 2a of the suppository container 2 is sealed to form a seal portion 2a ', whereby the suppository package 5 according to the present invention is manufactured as shown in FIG. 2 (b). . In the present embodiment, since the space inside the suppository container 2 is densely filled with the filler 4, when the inlet 2a is sealed, a part of the filler 4 is sandwiched between the sealing portions, and both are sealed. However, since the filler 4 itself has a function as a sealing material, the hermeticity inside the suppository package 5 is completely maintained during storage and / or distribution. That is, in the suppository package 5 thus manufactured, since the filler 4 is sealed in the suppository container 2 via the seal portion 2a, the filler 4 is used for the suppository. The suppository container 2 can be more securely sealed by being integrated with the seal portion 2a 'of the container 2. Therefore, in the present embodiment, the contact between the suppository and the outside world can be completely cut off, so that the suppository 1 contained in the suppository container 2 is kept in a safe and good state until use. can do.
図 2 (b )から明らかなように、 本実施の形態の坐剤梱包体 5ではその内部に坐 剤 1が移動可能な空間が存在しないので、 保存及び/又は流通過程において坐剤 梱包体 5が体温以上の温度条件下におかれて、坐剤 1が溶融した場合であっても、 坐剤用コンテナ 2内で坐剤 1が移動することがない。 したがって、 高温下で坐剤 梱包体 5が横転又は天地逆転しても坐剤 1の元の形状を維持することができる。 なお、 坐剤 1は溶融時に体積が僅かに増加するが、 この増加はコンテナ 2の膨脹 によって吸収することができる。 As is clear from FIG. 2 (b), the suppository package 5 of the present embodiment Since there is no space in which the suppository 1 can move, even if the suppository 1 is melted when the suppository package 5 is kept at a temperature equal to or higher than the body temperature during the storage and / or distribution process, Suppository 1 does not move in container 2 for use. Therefore, the original shape of the suppository 1 can be maintained even when the suppository package 5 is turned over or turned upside down at a high temperature. Suppository 1 slightly increases in volume when melted, but this increase can be absorbed by the expansion of container 2.
また、 図 2 (b)に示されるように、 坐剤梱包体 5では、 坐剤 1の長軸 Z方向に 沿った端部の周囲の空間のみが充填材 4によって充填されているために、 充填材 4は坐剤 1の表面を広範囲に被覆することがない。 したがって、 コンテナ 2を開 封した際に、 坐剤 1の取り出しが容易である。  In addition, as shown in FIG. 2 (b), in the suppository package 5, only the space around the end along the long axis Z direction of the suppository 1 is filled with the filler 4, Filler 4 does not cover the surface of suppository 1 extensively. Therefore, when container 2 is opened, suppository 1 can be easily taken out.
さらに、 本実施の形態の坐剤梱包体 5においては、 充填材 4が坐剤用コンテナ 2と一体化しているので、 図 3に示すように、 使用時に坐剤用コンテナ 2を開封 しても充填材 4が坐剤用コンテナ 2から外れることがない。 したがって、 使用者 が坐剤用コンテナ 2から坐剤 1を取り出す際に、 充填材 4を誤って取り出すおそ れがない。また、坐剤 1を取り出した後の坐剤梱包体の廃棄処理等も容易である。 しかも、 充填材 4が坐剤用コンテナ 2に固定されているので、 保存又は流通段階 において充填材 4が移動して坐剤 1の形状に影響を与えることもない。 実施例  Further, in the suppository package 5 of the present embodiment, since the filler 4 is integrated with the suppository container 2, even if the suppository container 2 is opened during use as shown in FIG. The filler 4 does not come off the suppository container 2. Therefore, when the user removes the suppository 1 from the suppository container 2, there is no danger that the filler 4 will be removed by mistake. Further, disposal of the suppository package after removing the suppository 1 is easy. In addition, since the filler 4 is fixed to the suppository container 2, the filler 4 does not move during storage or distribution, and does not affect the shape of the suppository 1. Example
実施例に用いた坐剤は常法により調製した。 その組成と性状を表 1に示す。 次 に、 ポリエチレンを内側にラミネ一トしたポリプロピレン製の坐剤用コンテナに 1 . 5 gの溶融した坐剤を充填した。 前記坐剤の固化後、 この上に溶融したポリ 酢酸ビニル系のホヅ トメルト型接着剤 0 . 5 gを素速く充填し、 直ちにヒートシ 一ラーで坐剤用コンテナ入口を密封して坐剤梱包体を得た。 表 1 実施例における坐剤の組成及び性状 薬剤 ·含量 ( 1個中) 吉草酸ジフルコルトロン 0 . 2 m g 基剤 ノヽ一ドファヅ ト  The suppositories used in the examples were prepared by a conventional method. Table 1 shows the composition and properties. Next, 1.5 g of molten suppository was filled in a polypropylene suppository container having polyethylene laminated inside. After the suppository was solidified, 0.5 g of the melted polyvinyl acetate-based hot-melt adhesive was quickly filled thereon, and the suppository container inlet was immediately sealed with a heat sealer to seal the suppository package. I got Table 1 Composition and properties of suppositories in Examples Drugs / Content (per one) Diflucortron valerate 0.2 mg Base powder
性状 白色〜微黄色 上記のようにして得られた坐剤梱包体 2 0個を、 天地を逆転して 4 5。Cの恒温 槽に 1時間保存した後に 2 5 °Cの室内に 1 日間静置した。 その結果、 試験に供し た 2 0個のサンプルのいずれについても、 坐剤用コンテナからの坐剤の漏洩はな かった。 また、 坐剤用コンテナから坐剤を取り出したところ、 坐剤には変形が認 められなかった。 産業上の利用可能性 Property White to pale yellow The 20 suppository packs obtained as described above were turned upside down 45. After storing in a C thermostat for 1 hour, it was left still in a room at 25 ° C for 1 day. As a result, no suppository leaked from the suppository container in any of the 20 samples subjected to the test. When the suppository was removed from the suppository container, no deformation was observed in the suppository. Industrial applicability
本発明の坐剤梱包体によれば、 坐剤梱包体が体温以上の温度条件下で保存及び /又は流通され、 横転又は天地逆転されたとしても、 坐剤用コンテナ内に保持さ れる坐剤の形状が変形することがない。 坐剤の流動開始温度が 5 0 °C以上の場合 には、 坐剤の変形をより確実に防止することができる。  According to the suppository package of the present invention, even if the suppository package is stored and / or circulated under a temperature condition equal to or higher than the body temperature and is turned over or turned upside down, the suppository is held in the suppository container. Is not deformed. When the flow starting temperature of the suppository is 50 ° C or more, deformation of the suppository can be more reliably prevented.
また、 坐剤の端部に隣接した空間のみに充填材が充填された場合には、 コンテ ナからの坐剤の取り出しが容易となり、 使用性が向上する。  Also, when the filler is filled only in the space adjacent to the end of the suppository, the suppository can be easily taken out of the container and the usability is improved.
坐剤用コンテナ内の充填材が坐剤用コンテナと固着されている場合は、 使用者 が坐剤用コンテナから坐剤を取り出す際に、 充填材を誤って取り出すおそれがな く、 また、 使用後の廃棄処理等を容易に行うことができる。 さらに、 充填材が坐 剤用コンテナ内で移動することがないので坐剤の形状に影響を与えることがな レ、。 特に、 前記充填材が坐剤用コンテナのシール部と一体化している場合には、 上記した効果の他に、 該シール部の封止がより確実となり、 坐剤を外界から遮断 してより安全に保持することが可能となる。  If the filler in the suppository container is fixed to the suppository container, there is no danger that the filler will accidentally remove the filler when removing the suppository from the suppository container. Subsequent disposal can be easily performed. Furthermore, the filler does not move in the suppository container, so it does not affect the shape of the suppository. In particular, when the filler is integrated with the seal portion of the suppository container, in addition to the above-described effects, the sealing of the seal portion becomes more reliable, and the suppository is shielded from the outside world, thereby providing a more secure Can be held.
前記充填材が溶出成分を含まない場合には、 人体に好ましくない化学物質等が 坐剤へ移行することを回避することができる。 また、 前記充填材がホッ トメルト 型接着剤である場合には、 坐剤用コンテナとの一体化及びシールを容易に行うこ とができる。  When the filler does not contain an eluting component, it is possible to prevent a chemical substance or the like that is not desirable for the human body from migrating to a suppository. When the filler is a hot-melt adhesive, integration with a suppository container and sealing can be easily performed.
本発明の方法によれば、 体温以上の温度条件下で保存乃至流通され、 横転又は 天地逆転されたとしても、 坐剤の形状が崩れることがない坐剤梱包体を得ること ができる。 坐剤と充填材とを同一のコンテナ入口を介してコンテナ内に導入する 場合には、 坐剤梱包体の製造がより容易となり作業効率が向上する。 そして、 コ ンテナ入口を充填材と共にシールする場合には、 該シール部の封止をより確実に 行うことができる。 According to the method of the present invention, it is possible to obtain a suppository package in which the shape of the suppository is not lost even if the suppository is stored or distributed under a temperature condition equal to or higher than the body temperature and turned over or upside down. When a suppository and a filler are introduced into a container through the same container entrance, production of a suppository package becomes easier and work efficiency is improved. And In the case where the inlet of the antenna is sealed together with the filler, the sealing portion can be more reliably sealed.

Claims

請求の範囲 The scope of the claims
1 . 坐剤と、 1. Suppositories,
前記坐剤を包含するコンテナとからなる坐剤梱包体であって、  A suppository package comprising a container containing the suppository,
前記坐剤と前記コンテナとの間の空間の全てが充填材によって充填されている ことを特徴とする坐剤梱包体。  A suppository package, wherein the entire space between the suppository and the container is filled with a filler.
2 . 前記空間が前記坐剤の端部のみに隣接して存在することを特徴とする請求項 1記載の坐剤梱包体。 2. The suppository package according to claim 1, wherein the space exists only adjacent to an end of the suppository.
3 . 前記充填材の流動開始温度が 5 0 °C以上であることを特徴とする、 請求項 1 又は 2記載の坐剤梱包体。 3. The suppository package according to claim 1, wherein a flow start temperature of the filler is 50 ° C. or higher.
4 . 前記充填材が前記コンテナに固着されていることを特徴とする請求項 1乃至 3のいずれかに記載の坐剤梱包体。 4. The suppository package according to any one of claims 1 to 3, wherein the filler is fixed to the container.
5 . 前記コンテナがシール部を備えており、 前記充填材が当該シール部と一体化 されていることを特徴とする請求項 1乃至 4のいずれかに記載の坐剤梱包体。 5. The suppository package according to any one of claims 1 to 4, wherein the container has a seal portion, and the filler is integrated with the seal portion.
6 . 前記充填材が溶出成分を含まないことを特徴とする請求項 1乃至 5のいずれ かに記載の坐剤梱包体。 6. The suppository package according to any one of claims 1 to 5, wherein the filler does not contain an eluted component.
7 . 前記充填材がホッ トメルト型接着剤であることを特徴とする請求項 1乃至 6 のいずれかに記載の坐剤梱包体。 7. The suppository package according to any one of claims 1 to 6, wherein the filler is a hot melt adhesive.
8 . 坐剤をコンテナ入口よりコンテナの内部に導入する導入工程、 8. Introducing the suppository into the container from the container entrance,
前記坐剤と前記コンテナとの間の空間に流動状の充填材を充填する充填工程、 及び、  A filling step of filling a space between the suppository and the container with a fluid filler, and
前記コンテナ入口をシールする封止工程を含む、 坐剤梱包体の製造方法。 A method for producing a suppository package, comprising a sealing step of sealing the container entrance.
9 . 前記導入工程が、 流動状の坐剤をコンテナ内に注入する工程、 及び、 前記坐 剤を固化させる工程を含む、 請求項 8記載の製造方法。 9. The method according to claim 8, wherein the introducing step includes a step of injecting a fluid suppository into a container, and a step of solidifying the suppository.
1 0 . 前記充填工程における充填が前記コンテナ入口を介して行われることを特 徴とする、 請求項 8又は 9記載の製造方法。 10. The manufacturing method according to claim 8, wherein the filling in the filling step is performed through the container inlet.
1 1 . 前記充填材の流動開始温度が 5 0 °C以上であることを特徴とする請求項 8 乃至 1 0のいずれかに記載の製造方法。 11. The method according to claim 8, wherein the flow start temperature of the filler is 50 ° C. or higher.
1 2 . 前記封止工程において、 前記充填材と共に前記コンテナ入口をシールする ことを特徴とする請求項 8乃至 1 1のいずれかに記載の製造方法。 12. The method according to any one of claims 8 to 11, wherein in the sealing step, the container inlet is sealed together with the filler.
1 3 . 前記充填材が溶出成分を含まないことを特徴とする請求項 8乃至 1 2のい ずれかに記載の製造方法。 13. The method according to any one of claims 8 to 12, wherein the filler does not contain an eluted component.
1 4 . 前記充填材がホッ トメルト型接着剤であることを特徴とする請求項 8乃至 1 3のいずれかに記載の製造方法。 14. The method according to any one of claims 8 to 13, wherein the filler is a hot melt adhesive.
1 5 . 請求項 8乃至 1 4のいずれかに記載の方法によって得られる坐剤梱包体。 15. A suppository package obtained by the method according to any one of claims 8 to 14.
1 6 . 坐剤及び当該坐剤を包含するコンテナとからなる坐剤梱包体において、 当 該コンテナ内の空間に流動状の充填材を充填することを含む坐剤の変形防止方 16. In a suppository package comprising a suppository and a container containing the suppository, a method for preventing deformation of the suppository, which comprises filling a space in the container with a fluid filler.
1 7 . 前記充填材の流動開始温度が 5 0 °C以上であることを特徴とする請求項 1 6記載の方法。 17. The method according to claim 16, wherein the flow start temperature of the filler is 50 ° C or higher.
PCT/JP2000/001761 1999-03-23 2000-03-23 Suppository package and production method therefor WO2000056263A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU33256/00A AU3325600A (en) 1999-03-23 2000-03-23 Suppository package and production method therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11078691A JP2000271189A (en) 1999-03-23 1999-03-23 Suppository packing body and manufacture therefor
JP11/78691 1999-03-23

Publications (1)

Publication Number Publication Date
WO2000056263A1 true WO2000056263A1 (en) 2000-09-28

Family

ID=13668901

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2000/001761 WO2000056263A1 (en) 1999-03-23 2000-03-23 Suppository package and production method therefor

Country Status (3)

Country Link
JP (1) JP2000271189A (en)
AU (1) AU3325600A (en)
WO (1) WO2000056263A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2142034A1 (en) * 1971-08-21 1973-03-01 Franco Pozzi PROCESS FOR THE CONTINUOUS MANUFACTURING OF CONTAINERS FROM PLASTIC MATERIAL, IN PARTICULAR FOR SUPPOSITORIES AND THE LIKE. AND DEVICE FOR CARRYING OUT THE PROCEDURE
JPS5882869A (en) * 1981-11-06 1983-05-18 岡本 「あ」吉 Suppository molding packing
JPS63260562A (en) * 1987-04-16 1988-10-27 松本 光雄 Container for hollow suppository and its production
EP0459818A1 (en) * 1990-05-31 1991-12-04 Taisho Pharmaceutical Co. Ltd Peel-openable container for suppository

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2142034A1 (en) * 1971-08-21 1973-03-01 Franco Pozzi PROCESS FOR THE CONTINUOUS MANUFACTURING OF CONTAINERS FROM PLASTIC MATERIAL, IN PARTICULAR FOR SUPPOSITORIES AND THE LIKE. AND DEVICE FOR CARRYING OUT THE PROCEDURE
JPS5882869A (en) * 1981-11-06 1983-05-18 岡本 「あ」吉 Suppository molding packing
JPS63260562A (en) * 1987-04-16 1988-10-27 松本 光雄 Container for hollow suppository and its production
EP0459818A1 (en) * 1990-05-31 1991-12-04 Taisho Pharmaceutical Co. Ltd Peel-openable container for suppository

Also Published As

Publication number Publication date
JP2000271189A (en) 2000-10-03
AU3325600A (en) 2000-10-09

Similar Documents

Publication Publication Date Title
AU780424B2 (en) Injection-moulded water-soluble container
US20100044924A1 (en) Candle refill kit and method of use
AT413942B (en) METHOD FOR PRODUCING PACKAGING SYSTEMS FOR TECHNICAL AND PHARMACEUTICAL INDIVIDUAL DOSING
ZA200204662B (en) Injection-moulded water-soluble container.
EP0173293B1 (en) Hot melt antihistamine formulations
HU215364B (en) Method for making transdermal medicament supplying system being closed by ultrasound
US8443793B2 (en) Heating apparatus
WO2000056263A1 (en) Suppository package and production method therefor
US5037698A (en) Capsule filling employing hygroscopic components
WO2004037671A1 (en) Packaged hot melt adhesive and method
DE19945849A1 (en) Detergent for machine washing or cleaning, especially machine dish-washing, contains component active in the first washing stage and component active in another stage, packed together in portion pack
US11109612B2 (en) Instant hot water drinks
CA2154497A1 (en) Production technique for blocks of hot melt adhesives
JPH0613729Y2 (en) Drug container
TWI812925B (en) Composite multilayer structure for biodegradable cleaning and method of making same
JPH0346520B2 (en)
JP2023095718A (en) Manufacturing method of stick product
CN115998938A (en) Functional capsule for disposable sanitary article and disposable sanitary article
WO2001060340A1 (en) Delivery capsules
GB2376676A (en) Rigid water-soluble containers
DE102004030148B4 (en) Process for the preparation of portion packs for washing or cleaning substances
GB2361643A (en) Two-layer capsules
AU2022285106A1 (en) Water-soluble films and packages
JPH078292B2 (en) Hollow suppository container and manufacturing method thereof
EP3489334A1 (en) A method of manufacturing of pillar candles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CN KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase